BREAKWATER phase 3: Post hoc subgroup analyses by age in patients (pts) with BRAF V600E-mutant metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology 2026

View at publisher
Authors: Cathy Eng, Scott Kopetz, Josep Tabernero, Elena M Elez, Takayuki Yoshino, Eric Van Cutsem, Harpreet Singh Wasan, Van Karlyle Morris, Tiziana Usari, Khyati Niral Shah, Nana Rezai, Xiaosong Zhang
+1 more Jeanne Tie
DOI: 10.1200/jco.2026.44.2_suppl.122
Cited by: 1

Abstract

122 Background: Most mCRC occurs in pts ≥50 y old but increasingly pts

Fields of Study & Subjects

Colorectal Cancer Treatments and Studies Cancer Genomics and Diagnostics Advanced Breast Cancer Therapies

Publication details

Journal / source
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Volume
44
Issue
2_suppl
Pages
122–122
Publication date
10 January 2026
Language
EN